Restaging of Patients with Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy Using [68Ga]-PSMA-11 Positron Emission Tomography/Computed Tomography: Impact on Disease Management

被引:2
|
作者
Gauthe, Mathieu [1 ]
Sargos, Paul [2 ]
Ouaritini, Nicolas Benziane [2 ]
Barret, Eric [3 ]
Beauval, Jean-Baptiste [4 ]
Brureau, Laurent [5 ]
Crehange, Gilles [6 ]
Dariane, Charles [7 ]
Fiard, Gaelle [8 ]
Fromont, Gaelle [9 ]
Mathieu, Romain [10 ]
Renard-Penna, Raphaele [11 ]
Roubaud, Guilhem [12 ]
Ruffion, Alain [13 ]
Roupret, Morgan [14 ]
Ploussard, Guillaume [4 ,15 ]
机构
[1] Scintep, Dept Nucl Med, Grenoble, France
[2] Inst Bergonie, Dept Radiotherapy, Bordeaux, France
[3] Inst Mutualiste Montsouris, Dept Urol, Paris, France
[4] La Croix Sud Hosp, Dept Urol, Quint Fonsegrives, France
[5] Univ Antilles, Dept Urol, CHU Pointe A Pitre, Pointe A Pitre, Guadeloupe, France
[6] Inst Curie, Dept Radiat Oncol, Paris, France
[7] Univ Paris, Hop Europeen Georges Pompidou, AP HP Paris, Dept Urol, Paris, France
[8] Univ Grenoble Alpes, Grenoble Alpes Univ Hosp, Dept Urol, Grenoble, France
[9] CHRU, Dept Pathol, Tours, France
[10] CHU Rennes, Dept Urol, Rennes, France
[11] Sorbonne Univ, Pitie Salpetriere Hosp, AP HP, Dept Radiol, Paris, France
[12] Inst Bergonie, Dept Med Oncol, Bordeaux, France
[13] Univ Lyon 1, Hosp Civils Lyon, Ctr Hosp Lyon Sud, Serv dUrol, Lyon, France
[14] Sorbonne Univ, Pitie Salpetriere Hosp, AP HP, GRC 5 Predict Onco Urol, Paris, France
[15] Inst Univ Canc Oncopole, Toulouse, France
关键词
D O I
10.1016/j.eururo.2022.01.012
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E87 / E89
页数:3
相关论文
共 50 条
  • [1] [68Ga]PSMA-11 for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA)-positive lesions in men with prostate cancer
    Clore, Jessica
    Scott, Peter J. H.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2024,
  • [2] Localization and restaging of carcinoma prostate by 68Gallium prostate-specific membrane antigen positron emission tomography computed tomography in patients with biochemical recurrence
    Seniaray, Nikhil
    Verma, Ritu
    Khanna, Sudhir
    Belho, Ethel
    Pruthi, Ankur
    Mahajan, Harsh
    INDIAN JOURNAL OF UROLOGY, 2020, 36 (03) : 191 - 199
  • [3] The Role of Choline Positron Emission Tomography/Computed Tomography in the Management of Patients with Prostate-Specific Antigen Progression After Radical Treatment of Prostate Cancer
    Picchio, Maria
    Briganti, Alberto
    Fanti, Stefano
    Heidenreich, Axel
    Krause, Bernd J.
    Messa, Cristina
    Montorsi, Francesco
    Reske, Sven N.
    Thalmann, George N.
    EUROPEAN UROLOGY, 2011, 59 (01) : 51 - 60
  • [4] CLINICAL IMPACT OF GALLIUM-PROSTATE SPECIFIC MEMBRANE ANTIGEN (GA-PSMA) POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY (PET/CT) IN PATIENTS WITH PROSTATE CANCER AND BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY
    Mosquera, Aysa
    Varela, Rodolfo
    Abrera, Marino
    Godoy, Fabian
    de Mesa, Byron Lopez
    Forero, Jorge
    Becerra, Luis
    Camacho, Diego
    Serna, Laura
    JOURNAL OF UROLOGY, 2021, 206 : E1013 - E1013
  • [5] Response assessment using 68 Gallium (68Ga) Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography - Computed Tomography (PT/CT) inpatients with oligometastatic prostate cancer undergoing Stereotactic Body Radiotherapy (SBRT)
    Sadetskii, I.
    Eshet, Y.
    Tsvang, L.
    Amit, U.
    Weiss, I.
    Benayun, M.
    Lawrence, Y.
    Symon, Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E572 - E573
  • [6] How does 68Ga-prostate-specific membrane antigen positron emission tomography/computed tomography impact the management of patients with prostate cancer recurrence after surgery?
    Bianchi, Lorenzo
    Schiavina, Riccardo
    Borghesi, Marco
    Ceci, Francesco
    Angiolini, Andrea
    Chessa, Francesco
    Droghetti, Matteo
    Bertaccini, Alessandro
    Manferrari, Fabio
    Marcelli, Emanuela
    Cochetti, Giovanni
    Porreca, Angelo
    Castellucci, Paolo
    Fanti, Stefano
    Brunocilla, Eugenio
    INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 (08) : 804 - 811
  • [7] The Role of Positron Emission Tomography With 68Gallium (Ga)-Labeled Prostate-specific Membrane Antigen (PSMA) in the Management of Patients With Organ-confined and Locally Advanced Prostate Cancer Prior to Radical Treatment and After Radical Prostatectomy
    Rai, Bhavan Prasad
    Baum, Richard Paul
    Patel, Amit
    Hughes, Robert
    Alonzi, Roberto
    Lane, Tim
    Adshead, Jim
    Vasdev, Nikhil
    UROLOGY, 2016, 95 : 11 - 15
  • [8] The Role of Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography in the Management of Patients With Prostate Cancer: Implications for Selection of Patients for Radiation Therapy
    Amit, U.
    Goldstein, J. D.
    Davidson, T.
    Hahiashvili, M.
    Goshen, E.
    Oksman, Y.
    Berger, R.
    Saad, A.
    Sadetsky, I.
    Chikman, B.
    Lawrence, Y. R.
    Ben-Haim, S.
    Symon, Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S112 - S113
  • [9] Clinical impact of 68Ga-prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) in patients with prostate cancer with rising prostate-specific antigen after treatment with curative intent: preliminary analysis of a multidisciplinary approach
    Albisinni, Simone
    Artigas, Carlos
    Aoun, Fouad
    Biaou, Ibrahim
    Grosman, Julien
    Gil, Thierry
    Hawaux, Eric
    Limani, Ksenija
    Otte, Francois-Xavier
    Peltier, Alexandre
    Sideris, Spyridon
    Sirtaine, Nicolas
    Flamen, Patrick
    van Velthoven, Roland
    BJU INTERNATIONAL, 2017, 120 (02) : 197 - 203
  • [10] Stellenwert der PSMA-PET/CT („prostate-specific membrane antigen positron emission tomography/computed tomography“) im Rahmen des StagingsRole of prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA-PET/CT) in staging
    Claudia Kesch
    Tobias Franiel
    Christoph Berliner
    Wolfgang P. Fendler
    Ken Herrmann
    Boris Hadaschik
    Die Urologie, 2025, 64 (3) : 220 - 228